Private and public sectors have collaborated to launch a biopharmaceutical company to produce protein drugs, with the intention of helping local companies manufacture such drugs for clinical trials.
INVESTORS
Active pharmaceutical ingredient maker Formosa Laboratories Inc (台耀化學), the government-funded Development Center for Biotechnology (DCB) and the state-run National Development Fund are all investors in EirGenix Inc (台康生技), capitalized at NT$540 million (US$18.17 million).
DCB and Formosa Laboratories each have an 18 percent holding in the new company launched yesterday, while the National Development Fund has a 12 percent stake.
EirGenix has the capacity to produce 800 liters of protein drugs and is set to expand its capacity to 1,500 liters in the second quarter of next year, and to 30,000 liters within eight to 10 years, EirGenix chief executive officer Liu Lee-cheng (劉理成) said.
BREAST CANCER
The company is also developing a generic drug for treating breast cancer, and the company estimated the worldwide market for such a drug to be US$6 billion, according to Liu.
EirGenix is set to break even in 2016 and become a listed company in Taiwan in 2017, Liu said.
PROTECTIONISM: China hopes to help domestic chipmakers gain more market share while preparing local tech companies for the possibility of more US sanctions Beijing is stepping up pressure on Chinese companies to buy locally produced artificial intelligence (AI) chips instead of Nvidia Corp products, part of the nation’s effort to expand its semiconductor industry and counter US sanctions. Chinese regulators have been discouraging companies from purchasing Nvidia’s H20 chips, which are used to develop and run AI models, sources familiar with the matter said. The policy has taken the form of guidance rather than an outright ban, as Beijing wants to avoid handicapping its own AI start-ups and escalating tensions with the US, said the sources, who asked not to be identified because the
Taipei is today suspending its US$2.5 trillion stock market as Super Typhoon Krathon approaches Taiwan with strong winds and heavy rain. The nation is not conducting securities, currency or fixed-income trading, statements from its stock and currency exchanges said. Yesterday, schools and offices were closed in several cities and counties in southern and eastern Taiwan, including in the key industrial port city of Kaohsiung. Taiwan, which started canceling flights, ship sailings and some train services earlier this week, has wind and rain advisories in place for much of the island. It regularly experiences typhoons, and in July shut offices and schools as
Her white-gloved, waistcoated uniform impeccable, 22-year-old Hazuki Okuno boards a bullet train replica to rehearse the strict protocols behind the smooth operation of a Japanese institution turning 60 Tuesday. High-speed Shinkansen trains began running between Tokyo and Osaka on Oct. 1, 1964, heralding a new era for rail travel as Japan grew into an economic superpower after World War II. The service remains integral to the nation’s economy and way of life — so keeping it dazzlingly clean, punctual and accident-free is a serious job. At a 10-story, state-of-the-art staff training center, Okuno shouted from the window and signaled to imaginary colleagues, keeping
FALLING BEHIND: Samsung shares have declined more than 20 percent this year, as the world’s largest chipmaker struggles in key markets and plays catch-up to rival SK Hynix Samsung Electronics Co is laying off workers in Southeast Asia, Australia and New Zealand as part of a plan to reduce its global headcount by thousands of jobs, sources familiar with the situation said. The layoffs could affect about 10 percent of its workforces in those markets, although the numbers for each subsidiary might vary, said one of the sources, who asked not to be named because the matter is private. Job cuts are planned for other overseas subsidiaries and could reach 10 percent in certain markets, the source said. The South Korean company has about 147,000 in staff overseas, more than half